SEC Form 4 · accession 0001237899-16-000081
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Larosa
Officer — SVP General Counsel and Secret
Period of report
Sep 1, 2016
Accepted (ET)
Sep 2, 2016 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2016 | F | 4,943 | $392.63 | D | 11,813 | D | |
| Common Stock | holding | — | — | — | 141 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.